Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis
Abstract Gene targeting of Cdc42 GTPase has been shown to inhibit platelet activation. In this study, we investigated a hypothesis that inhibition of Cdc42 activity by CASIN, a small molecule Cdc42 Activity-Specific INhibitor, may down regulate platelet activation and thrombus formation. We investig...
Guardado en:
Autores principales: | Xin Duan, Rehana Perveen, Akhila Dandamudi, Reheman Adili, James Johnson, Kevin Funk, Mark Berryman, Ashley Kuenzi Davis, Michael Holinstat, Yi Zheng, Huzoor Akbar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4e0ab58442d54fbc9bafc38cdf9a72ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Optogenetic dissection of Rac1 and Cdc42 gradient shaping
por: S. de Beco, et al.
Publicado: (2018) -
A Cdc42/RhoA regulatory circuit downstream of glycoprotein Ib guides transendothelial platelet biogenesis
por: Sebastian Dütting, et al.
Publicado: (2017) -
TRPV4 activates the Cdc42/N-wasp pathway to promote glioblastoma invasion by altering cellular protrusions
por: Wei Yang, et al.
Publicado: (2020) -
Eng2, a new player involved in feedback loop regulation of Cdc42 activity in fission yeast
por: Patricia García, et al.
Publicado: (2021) -
EPEC Recruits a Cdc42-Specific GEF, Frabin, To Facilitate PAK Activation and Host Cell Colonization
por: Vikash Singh, et al.
Publicado: (2020)